Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.

The Properdin System and Immunity: I. Demonstration and Isolation of a New Serum Protein, Properdin, and Its Role in Immune Phenomena

1954 • 940 citations

ISOLATION OF A FRAGMENT (C3a) OF THE THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUM

1969 • 430 citations

Detection of Antibodies and Soluble Antigen-Antibody Complexes by Precipitation with Polyethylene Glycol

1973 • 422 citations

ISOLATION OF ß1F-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT

1965 • 416 citations

Deoxyribonucleic Acid Antibody: A Method to Detect Its Primary Interaction with Deoxyribonucleic Acid

1968 • 381 citations

Studies of the In Vivo Behavior of Human C′3 in Normal Subjects and Patients*

1967 • 229 citations

Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3).

1973 • 160 citations

Metabolic Studies of the Third Component of Complement and the Glycine-Rich Beta Glycoprotein in Patients with Hypocomplementemia

1974 • 156 citations

The alternate pathway of complement activation. The role of C3 and its inactivator (KAF).

1973 • 153 citations

The Complement Profile in Acute Glomerulonephritis Systemic Lupus erythematosus and Hypocomplementemic Chronic Glomerulonephritis

1968 • 140 citations

Metabolism of Third Complement Component (C3) in Nephritis

1972 • 130 citations

Complement in Human Disease

1968 • 114 citations

Breakdown products of C′3 in human synovial fluids

1969 • 95 citations

Properdin and C3 Proactivator: Alternate Pathway Components in Human Glomerulonephritis

1973 • 95 citations

Alternate Complement Pathway: Factors Involved in Cobra Venom Factor (CoVF) Activation of the Third Component of Complement (C3)

1973 • 93 citations

Decreased synthesis of the third component of complement (C3) in hypocomplementemic systemic lupus erythematosus.

1972 • 79 citations

Evidence for In Vivo Breakdown of β1C-Globulin in Hypocomplementemic Glomerulonephritis *

1967 • 72 citations

The Complement System of Man

1972 • 65 citations

Anti-nuclear factors and serum complement in systemic lupus erythematosus.

1962 • 64 citations

Circulating conversion products of C3 in liver disease. Evidence for in vivo activation of the complement system.

1973 • 47 citations

Quantitation of C3PA (properdin factor B) and other complement components in diseases associated with a low C3 level

1973 • 47 citations

Changes in Antigenic Properties of Human C3 upon Activation and Conversion by Trypsin

1974 • 42 citations

VARIABLE MECHANISMS FOR LOW SERUM-COMPLEMENT IN LIVER DISEASE

1971 • 33 citations

Studies of the third component of complement in synovial fluid from arthritic patients. II. Conversion and its relation to total complement.

1970 • 32 citations

Altered complement component C3A (beta-1C--beta-1A) in patients with glomerulonephritis.

1967 • 27 citations

Serum complement after orthotopic transplantation of the human liver.

1972 • 22 citations

Studies of the third component of complement in synovial fluid from arthritic patients.

1970 • 20 citations

Genetic abnormalities of the complement system of man associated with disease.

1974 • 19 citations

Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.

1975 • 16 citations

Purification of human C3 proactivator by affinity chromatography

1974 • 5 citations

Purification of human C3 proactivator by affinity chromatography

1974 • 2 citations